[This Week's IPO] Demand Forecast and Subscription Schedule for the First Week of July

In the first week of this month (July), Shift Up and Excel Therapeutics will conduct public subscription offerings.

◆Shift Up= The desired public offering price range per share is 47,000 to 60,000 KRW, with the planned offering amount based on the upper limit of the price band at approximately 435 billion KRW. The public subscription is scheduled for July 2-3. The joint lead managers are Korea Investment & Securities, J.P. Morgan Securities, and NH Investment & Securities, with Shinhan Investment Corp. as the underwriter.

Shift Up is a global game developer. In 2016, the company released its first developed title, "Destiny Child." Its representative works include the mobile game "Goddess of Victory: NIKKE," released in 2022, and "Stella Blade," launched in April this year on Sony’s PlayStation 5 platform. "Stella Blade" is operated with Sony, the world's largest console platform operator, as its exclusive publishing partner. Shift Up is the first Korean game company to sign a second-party contract with Sony.

◆Excel Therapeutics= The desired public offering price per share is 6,200 to 7,700 KRW. Through this offering, it plans to raise approximately 10 billion to 12.5 billion KRW. Public subscription will be held on July 3-4. Daishin Securities is in charge of the listing management.

Excel Therapeutics is a specialized company in the development and production of "media," a core essential material in the advanced biopharmaceutical industry. Chemically Defined Media, which uses raw materials whose all components are chemically identified due to concerns such as virus infection risk and immunogenicity issues, is gaining attention as the next-generation media.